Atom Investors’s Ascendis Pharma A/S ASND Stock Holding History

Atom Investors’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.07M	Buy	+7,757	New	+$1.81M	0.18%	165
2026 Q1	–	Sell	-15,478	Closed	-$3.3M	–	661
2025 Q4	$3.3M	Buy	15,478 +6,147	+66%	+$1.27M	0.26%	133
2025 Q3	$1.86M	Sell	9,331 -4,107	-31%	-$766K	0.14%	177
2025 Q2	$2.32M	Buy	+13,438	New	+$2.19M	0.21%	140

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Atom Investors's ASND Position: Q2 2026 in Review

Atom Investors opened a new position in Ascendis Pharma A/S (ASND) in Q2 2026: 7,757 shares worth $2.07M. The stake represents 0.18% of the portfolio and ranks #165 among its holdings. This is a return to the name: Atom Investors previously reported a position in ASND as recently as Q4 2025.

Atom Investors first reported a position in ASND in Q2 2025 and has held it in 4 quarters since. The position peaked at $3.3M in Q4 2025. 311 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

Atom Investors held 7,757 shares of Ascendis Pharma A/S worth $2.07M as of Q2 2026.
Ascendis Pharma A/S was a new Atom Investors position in Q2 2026.
Ascendis Pharma A/S made up 0.18% of Atom Investors's portfolio in Q2 2026, its #165 holding.
Atom Investors first reported a position in Ascendis Pharma A/S in Q2 2025 and has held it in 4 quarters since.
Atom Investors's Ascendis Pharma A/S position peaked at $3.3M in Q4 2025.
311 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on Atom Investors's 13F filing for Q2 2026, filed 14 Aug 2026.